The PPAR-α agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a/β-catenin and activating PGC-1α: Involvement of network pharmacology and molecular docking

已完结 10 由星辰于我发布于 2025/7/3 9:56:57

DOI: 10.1016/j.ejphar.2025.177306
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.ejphar.2025.177306

Elsevier

Abstract：Liver damage is one of the most severe side effects of valproic acid (VPA) therapy. Research indicates that PPAR-α prevents Wnt3a/β-catenin-induced PGC-1α dysregulation, which is linked to l

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierPreparation of Eucommia ulmoides lignin-based high-performance biochar containing sulfonic group: Synergistic pyrolysis mechanism and tetracycline hydrochloride adsorption